Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kegong Tang"'
Autor:
Xinyi Du, Longxin Xu, Yiming Ma, Shuaiyao Lu, Kegong Tang, Xiangyu Qiao, Jiaqi Liu, Xiaona Wang, Xiaozhong Peng, Chengyu Jiang
Publikováno v:
IUBMB Life. 74:532-542
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf31d69514a9b0784590760663c073b0
https://doi.org/10.1002/iub.2616
https://doi.org/10.1002/iub.2616
Autor:
Kegong Tang, Xiaona Wang, Yu Zhao, Xiaobei Li, Zhenyu Jiang, Song Mei, Mingrui Chen, Yiming Ma, Xinyi Du, Xiangyu Qiao, Na Sun, Jiaqi Liu, Chengyu Jiang
Publikováno v:
Science China Life Sciences.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02f2d2d05b879847d27f9c4997599363
https://doi.org/10.1007/s11427-022-2275-3
https://doi.org/10.1007/s11427-022-2275-3
Autor:
Dandan Zhao, Yuhao Qin, Jiaqi Liu, Kegong Tang, Shuaiyao Lu, Zirui Liu, Yexuan Lin, Cong Zhang, Fengming Huang, Jiahui Chang, Chang Li, Mingyao Tian, Yiming Ma, Xiaoyun Li, Congzhao Zhou, Xiao Li, Xiaozhong Peng, Ningyi Jin, Chengyu Jiang
Publikováno v:
Science China Life Sciences.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2c6181b6ac4b320a46fb829e0ca2b4d
https://doi.org/10.1007/s11427-022-2219-0
https://doi.org/10.1007/s11427-022-2219-0
Autor:
Xinyi, Du, Longxin, Xu, Yiming, Ma, Shuaiyao, Lu, Kegong, Tang, Xiangyu, Qiao, Jiaqi, Liu, Xiaona, Wang, Xiaozhong, Peng, Chengyu, Jiang
Publikováno v:
IUBMB life. 74(6)
Coronavirus disease 2019, a newly emerging serious infectious disease, has spread worldwide. To date, effective drugs against the disease are limited. Traditional Chinese medicine was commonly used in treating COVID-19 patients in China. Here we trie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::effc59628b722804407ac2a10f4b2006
https://pubmed.ncbi.nlm.nih.gov/35383402
https://pubmed.ncbi.nlm.nih.gov/35383402
Autor:
Kegong Tang, Chengyu Jiang, Xinyi Du, Xiaobei Li, Song Mei, Jiaqi Liu, Yiming Ma, Xiaona Wang, Dandan Zhao, Shaoting Guo, Na Sun
Publikováno v:
Biochemical and biophysical research communications. 579
Rosiglitazone, a specific agonist of peroxisome proliferator-activated receptor-γ (PPAR-γ), displays a robust hypoglycemic action in patients with type 2 diabetes mellitus (T2DM) and elicits serious adverse reactions, especially hepatotoxicity and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3335c4623e3ebb82c5858fe4770fa99b
https://pubmed.ncbi.nlm.nih.gov/34607170
https://pubmed.ncbi.nlm.nih.gov/34607170